Skip to main content

Navigation group

Main content

Mission & scope

Acta Virologica (AV) aims to be the leading journal in the field by publishing open access premier research on molecular and cellular virology. Areas of interest are structure, genetics and morphology of viruses, molecular biology of virus-cell interactions, pathogenesis of viral diseases, viral immunology, vaccines, antiviral drugs and viral diagnostics. As a matter of tradition, rickettsiae are also included.

Editorial Board

Acta Virologica’s Editorial Board provides strategic and professional advice to the Editor-in-Chief. The journal recognises the following Editorial Board members for their continuous guidance and support of the journal:

Editor-in-Chief

Katarina Polcicova

Biomedical Research Center, Slovak Academy of Sciences

Deputy Editor

Juraj Kopacek

Biomedical Research Center, Slovak Academy of Sciences

Editors

Daniel Ruzek

Brno (Czech Republic)

Boris Klempa

Bratislava (Slovak Republic)

Viktoria Cabanova

Bratislava (Slovak Republic)

Peter Sabaka

Bratislava (Slovak Republic)

Zofia Radikova

Bratislava (Slovak Republic)

Ivana Nemcovicova

Bratislava (Slovak Republic)

Ivan Kosik

Bethesda (USA)

Miroslav Glasa

Bratislava (Slovak Republic)

Zdeno Subr

Bratislava (Slovak Republic)

Ludovit Skultety

Bratislava (Slovak Republic)

Eva Spitalska

Bratislava (Slovak Republic)

Amir Ghorbani

Bethesda (USA)

Nataša Knap

Ljubljana (Slovenia)

Join the Editorial Board

Call for Editorial Board Members

Acta Virologica is looking for new Editorial Board members, if you are interested in joining the Editorial Board as a Reviewer please complete this form.

Selection criteria

  • An active researcher with a PhD

  • Evidence of an active and relevant publication record for current career stage

  • Expertise in relevant subject areas within the scope of the journal

  • Experience of reviewing (desirable)

Although previous reviewing experience is desirable, we encourage applications from researchers at any stage of their career.

Key responsibilities

  • Reviewing manuscripts for the journal

  • Helping develop the journal including:

    • Suggesting Special Issues for the journal

    • Where relevant acting as a Guest Editor on a Special Issue

  • Acting as an ambassador for the journal at conferences and engaging with the journal through social media, as appropriate.

The journal is supported by a professional editorial office team which works to support all Editorial Board members in these activities.

Application assessment

Applications are assessed on submission and we aim to reply to all applicants within 4 weeks.

Journal Information

  • Short name

    Acta Virol.

  • Abbreviation

    av

  • Electronic ISSN

    1336-2305

  • Indexed in

    Chemical Abstracts Service (CAS), CrossRef, Current Contents/Clinical Medicine, DOAJ, Embase, Google Scholar, Scopus, Web of Science Science Citation Index Expanded (SCIE)

  • Impact

    1.1 Impact Factor

    3.1 CiteScore

Open Access Statement

Open access logo

Acta Virologica provides online free gold open access to the journal and all of its research publications. 

Open Access funder and institutional mandates: Acta Virologica is fully compliant with open access mandates, by publishing its articles under the Creative Commons Attribution licence (CC-BY). Funder mandates such as those by the Wellcome Trust (UK), National Institutes of Health (USA) and the Australian Research Council (Australia) are fully compatible with publishing in Acta Virologica. Authors retain copyright of their work and can deposit their publication in any repository. The work can be freely shared and adapted provided that appropriate credit is given and any changes specified.

Quality

Each Acta Virologica article strives for the highest quality, thanks to genuinely collaborative interactions between authors, editors and reviewers. Acta Virologica encourages authors to consult the instructions for authors guidelines prior to submission. Please observe that all submissions are screened for evidence of mass production of manuscripts, including ghostwritten, fabricated, or plagiarized text, generic titles, hypotheses, or experiments, and digital images that have been manipulated, manufactured, or re-used. These submissions will not be considered for peer review in Acta VirologicaActa Virologica operates in line with the research integrity principles supported by COPE.

Contact

Frontiers Editorial Office 

Avenue du Tribunal Fédéral 34 

CH – 1005 Lausanne 

Switzerland 

For queries regarding special issues, editorial board applications, fee support, and any other questions, please contact actavirol@frontierspartnerships.org 

For all queries regarding manuscripts in review or potential conflicts of interest, please contact actavirol.editorial.office@frontierspartnerships.org 

BMC Editorial Office 

Dubravska Cesta 9

84505 Bratislava

Slovak Republic

Tel: +421-2-59302-412

Frontiers IT HelpDesk 

For technical issues, please our IT HelpDesk team at support@frontierspartnerships.org